Hydrophobic Rose Bengal Derivatives Exhibit Submicromolar-to-Subnanomolar Activity against Enveloped Viruses

Biomolecules. 2022 Nov 1;12(11):1609. doi: 10.3390/biom12111609.

Abstract

Rose Bengal (RB) is an anionic xanthene dye with multiple useful biological features, including photosensitization properties. RB was studied extensively as a photosensitizer, mostly for antibacterial and antitumor photodynamic therapy (PDT). The application of RB to virus inactivation is rather understudied, and no RB derivatives have been developed as antivirals. In this work, we used a synthetic approach based on a successful design of photosensitizing antivirals to produce RB derivatives for virus photoinactivation. A series of n-alkyl-substituted RB derivatives was synthesized and evaluated as antiviral photosensitizers. The compounds exhibited similar 1O2 generation rate and efficiency, but drastically different activities against SARS-CoV-2, CHIKV, and HIV; with comparable cytotoxicity for different cell lines. Submicromolar-to-subnanomolar activities and high selectivity indices were detected for compounds with C4-6 alkyl (SARS-CoV-2) and C6-8 alkyl (CHIKV) chains. Spectrophotometric assessment demonstrates low aqueous solubility for C8-10 congeners and a significant aggregation tendency for the C12 derivative, possibly influencing its antiviral efficacy. Initial evaluation of the synthesized compounds makes them promising for further study as viral inactivators for vaccine preparations.

Keywords: 1O2 generation; Rose Bengal; antiviral activity; photosensitization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology
  • COVID-19 Drug Treatment*
  • Humans
  • Photosensitizing Agents / chemistry
  • Photosensitizing Agents / pharmacology
  • Rose Bengal* / chemistry
  • Rose Bengal* / pharmacology
  • SARS-CoV-2

Substances

  • Rose Bengal
  • Photosensitizing Agents
  • Antiviral Agents

Grants and funding

This work was funded by a grant from the Ministry of Science and Higher Education of Russian Federation (agreement No. 075-15-2021-1049 to AVA).